Nanox Vision

24/02/2026

Proud to see Nanox featured in Applied Radiology ahead of our showcase at next week! We’ll be presenting our end-to-end medical imaging advancements: from the Nanox.ARC system to AI solutions designed to enhance early detection and support better clinical decision-making, all focused on expanding access and improving patient outcomes. Exciting to bring these advancements to ECR. Read more:

Nanox’s vision for global medical imaging development is transformational, a combination of hardware, software, and service delivery that applies unique design and AI-based advancements to expand care. At ECR in Vienna, March 4-8, 2026, the company will showcase its Nanox.ARC digital tomosynthesis...

19/02/2026

Nanox Expands in Latin America with Exclusive Nanox.ARC Distribution.

Collaboration with Intec SRL drives commercial expansion of 3D medical imaging across a high-growth private healthcare market.

This collaboration supports the continued expansion of Nanox.ARC across Latin America and strengthens our presence in the region’s private healthcare sector.

Read more here: https://investors.nanox.vision/news-releases/news-release-details/nanox-expands-latin-america-exclusive-nanoxarc-distribution

17/02/2026

Nanox is showcasing its end-to-end imaging solutions, from scan to diagnosis.

Demonstrating the cutting-edge, CE-marked Nanox.ARC in Europe for the first time, and proven results from Nanox.AI solutions.


Read today’s announcement: https://investors.nanox.vision/news-releases/news-release-details/nanox-showcase-nanoxarc-live-europe-first-time-and-present-new

Schedule a meeting with us to learn more:
https://outlook.office.com/bookwithme/user/d23d548e352e4149b2d2b4ff193e6272%40nanox.vision/meetingtype/juC_vUTwy0GHCc4ED0XmZQ2?anonymous&ismsaljsauthenabled&utm_source=linkedin&utm_medium=organic_social&utm_campaign=book_meeting

03/02/2026

TAP2D a new Image Enhancement Capability for Nanox.ARC and Nanox.ARC X Systems

We’re proud to announce that Nanox has received FDA 510(k) clearance for TAP2D, a new image enhancement capability for Nanox.ARC and Nanox.ARC X Systems.
This milestone marks an important step forward toward the next phase of development, with the goal of ultimately removing the adjunct use in the U.S.
TAP2D provides radiologists with an additional, clear 2D image generated directly from the tomosynthesis scan, enabling both 3D and 2D views from a single scan, without exposing the patient to any additional radiation.

Learn more: https://investors.nanox.vision/news-releases/news-release-details/nanox-receives-fda-510k-clearance-tap2d-new-image-enhancement

24/06/2025

Nanox.ARC is reshaping hip imaging by delivering less than 7% of the radiation dose of an average CT scan, with a dose level almost identical to an average standard X-ray (only 1.1x higher).

This means patients benefit from enhanced diagnostic capabilities with minimal radiation exposure — making it a smart, safe choice for hip assessments.

Nanox.ARC: Precision you can trust, protection patients deserve.
https://www.nanox.vision/social-media-landing-page/

17/06/2025

When imaging extremities, Nanox.ARC offers a groundbreaking balance: delivering less than 2% of the radiation dose of a traditional CT scan — with approximately three times the dose of a standard X-ray.

Patients get diagnostic quality scans, providing additional information not available in Xray, with significantly reduced exposure over CT, helping to redefine safety and efficiency in medical imaging.

Discover a new era of smart imaging with Nanox.ARC: https://www.nanox.vision/social-media-landing-page/

10/06/2025

When it comes to imaging the lumbar spine, Nanox.ARC offers a remarkable balance between safety and clarity. With less than 9% of the radiation dose of an average CT scan, and only 20% additional dose to a standard X-ray, Nanox.ARC empowers providers to deliver more informed care — with minimal patient exposure.

Greater diagnostic value. Lower radiation burden.
This is spine imaging, reimagined.

Click here to learn more:
https://www.nanox.vision/social-media-landing-page/

03/06/2025

Digital tomosynthesis (DTS) is a breakthrough in imaging, bridging the gap between conventional X-ray and CT. It improves visualization and offers clinicians more diagnostic information while minimizing:

--> Radiation exposure – A fraction of a CT scan’s dose
--> Delays & complexities – Often no pre-authorization required
--> Costs – More affordable than CT

Until now, DTS systems were mostly inaccessible. Nanox.ARC is changing that.

Learn more: https://www.nanox.vision/

27/05/2025

Nanox.ARC is setting a new standard in medical imaging by delivering diagnostic-quality scans with considerably lower radiation exposure than CT. Most Nanox.ARC protocols deliver less than 20% of the dose required by standard CT for the same body parts, supporting patient safety while bringing valuable clinical insights.
Let’s build a safer future for medical imaging.

Click here to learn more:
https://www.nanox.vision/social-media-landing-page/

20/05/2025

With our new regulatory expansion, we're actively seeking distribution partners across LATAM and Europe.
Interested in joining our network? Get in touch with us today and lead the future of medical imaging!

ARCsales@nanox.vision

.ARC

14/05/2025

Transform Patient Care AND Drive Revenue with Nanox!

-> No upfront investment – in our Pay-per-scan model
-> Seamless implementation – Comprehensive support included

With minimal preauthorization in many cases, your facility can enhance diagnostics and profitability from Day 1.

Ready to elevate patient care and maximize revenue? Let’s talk! https://www.nanox.vision/nanox-arc/

11/05/2025

"AI in healthcare is more than just tech- it’s about people, processes, and real-world impact”. Erez Meltzer, CEO of Nanox, explores how AI is transforming patient care, from reducing ER wait times to detecting cancer earlier. The future is here- are we ready?

Read the full article here:
https://www.forbes.com/councils/forbestechcouncil/2025/05/09/healthcare-ai-what-it-can-do-and-where-its-heading/

The success of AI in healthcare is influenced more by human factors and organizational readiness than by the technology itself.